MSB 3.21% $1.13 mesoblast limited

Presentation on ASX Gems Conference on 21st June, page-107

  1. 2,886 Posts.
    lightbulb Created with Sketch. 2042
    GYG 3 Billion valuation - 10 million in earnings- no competitor protection- massive capital expense- changing casual employment laws- madness
    MSB 1.2 Billion valuation- 11 million in earnings- 1000 patents protection- two years stock on hand- awaiting first FDA approval- spec stock 3rd BLA chance


    I will stick with speculative biotech rather than rather basic burrito's


    Reg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.